HLAVÁČEK, Antonín, Zdeněk FARKA, Maria HUEBNER, Veronika HORŇÁKOVÁ, Daniel NĚMEČEK, Petr SKLÁDAL, Dietmar KNOPP a Hans-Heiner GORRIS. Determination of the Pharmaceutical Micropollutant Diclofenac in Fresh Water by Upconversion-Linked Immunosorbent Assay (ULISA). In EUROPT[R]ODE XIII. 2016.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Determination of the Pharmaceutical Micropollutant Diclofenac in Fresh Water by Upconversion-Linked Immunosorbent Assay (ULISA)
Autoři HLAVÁČEK, Antonín, Zdeněk FARKA, Maria HUEBNER, Veronika HORŇÁKOVÁ, Daniel NĚMEČEK, Petr SKLÁDAL, Dietmar KNOPP a Hans-Heiner GORRIS.
Vydání EUROPT[R]ODE XIII, 2016.
Další údaje
Originální jazyk angličtina
Typ výsledku Konferenční abstrakt
Obor 10600 1.6 Biological sciences
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Organizační jednotka Středoevropský technologický institut
Klíčová slova anglicky antibody; bioconjugation; diclofenac; immunoassay; pharmaceutical micropollutant; photon-upconversion
Příznaky Mezinárodní význam
Změnil Změnil: doc. Mgr. Zdeněk Farka, Ph.D., učo 357740. Změněno: 24. 2. 2019 17:34.
Anotace
Increasing number of publications report widespread occurrence of residues of human or veterinary pharmaceutics in the environment. Diclofenac, which is one of the most widely used non-steroidal anti-inflammatory drugs with analgetic, antipyretic and anti-inflammatory effects, belongs to the most frequently detected pharmaceuticals in the water-cycle in Europe. Diclofenac in low μg/L levels has been detected in waste water treatment plants, surface waters, groundwater pools as well as in drinking water (detected with GC/MS, LC-ESI/MS). Enzyme-Linked Immunosorbent Assay (ELISA) tests, which are based on analyte-specific antibodies, can be used in small laboratories and in the field for the monitoring of pharmaceuticals directly. Recently, photon-upconverting nanoparticles (UCNPs) emitting visible light under infrared excitation have been introduced as a new generation of luminescent labels for sensitive ”background free” detection. Such nanoparticles avoid time-consuming substrate conversion and overcome the inherent instability of enzyme molecules used in ELISA tests. We have developed the first heterogeneous immunochemical method for the detection of diclofenac utilizing UCNPs (silica coated 43 nm NaYF4 doped with Yb3+ and Er3+) as a signal amplifier. The bio-modification of UCNP with secondary anti-mouse IgG is described. The primary mouse monoclonal anti-diclofenac antibody enabled the competitive detection of diclofenac in environmental samples with a limit of detection of 0.34 ng/mL. The results have been compared to a conventional ELISA and LC-MS.
Návaznosti
ED1.1.00/02.0068, projekt VaVNázev: CEITEC - central european institute of technology
VytisknoutZobrazeno: 28. 7. 2024 16:52